Virtu Financial’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Virtu Financial’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,243	Closed	-$137K	–	3418
2017 Q3	$137K	Buy	+12,243	New	+$135K	0.01%	1994

Virtu Financial's SCLN Position: Q4 2017 in Review

Virtu Financial sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 12,243 shares — an estimated $137K sold.

Virtu Financial first reported a position in SCLN in Q3 2017 and held it in 1 quarter. The position peaked at $137K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Virtu Financial reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Virtu Financial sold 12,243 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $137K.
Virtu Financial first reported a position in Sciclone Pharmaceuticals Inc in Q3 2017 and held it in 1 quarter.
Virtu Financial's Sciclone Pharmaceuticals Inc position peaked at $137K in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Virtu Financial's 13F filing for Q4 2017, filed 9 Feb 2018.